510(k) · Cleared
ClearedImmage Immunochemistry System Apolipoprotein a-1 Reagent (Apa)/ Immage Immunochemistry System Apolipoprotein B Reagent
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Beckman Instruments, Inc. · MSJ Apolipoproteins
Cleared on Feb 10, 1997 as substantially equivalent to K862019 (Beckman Instruments, Inc., 1986) and 1 other predicate after a 126-day review. Its family tree reaches back 1 generation to 1986.
- Decided
- Feb 10, 1997
- Review
- 126 days
- Class
- Class I
- Product code
- MSJ
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 1 generation to K862019 (1986). 2 ancestors in all. No later device cites it as a predicate yet.
- Root · 1 generation backK862019 Ics Apolipoprotein a-1 Reagent Test KitBeckman Instruments, Inc. · 1986
- This deviceK964010 Immage Immunochemistry System Apolipoprotein a-1 Reagent (Apa)/…Beckman Instruments, Inc. · 1997
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K862019 | Ics Apolipoprotein a-1 Reagent Test Kit | Beckman Instruments, Inc. | 1986 | — |
| 0 (this device) | K964010 | Immage Immunochemistry System Apolipoprotein a-1 Reagent (Apa)/ Immage… | Beckman Instruments, Inc. | 1997 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1986 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in MSJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K862019 | Ics Apolipoprotein a-1 Reagent Test KitSummary page 1…protein B Reagent 3.2 Classification Names Lipoprotein test system (21 CFR 862.1475) Predicate Device(s): Beckman Immunochemistry Systems Apolipoprotein A-1 Reagent, K862019 Beckman Immunochemistry Systems Apolipoprotein B Reagent, K 862386 Description: The IMMAGE System Apolipoprotein A-1 (APA) and… | 1986 |
| * | K862386 | Ics Apolipoprotein B Reagent Test KitSummary page 1…em (21 CFR 862.1475) Predicate Device(s): Beckman Immunochemistry Systems Apolipoprotein A-1 Reagent, K862019 Beckman Immunochemistry Systems Apolipoprotein B Reagent, K 862386 Description: The IMMAGE System Apolipoprotein A-1 (APA) and B (APB) Reagents are designed for optimal performance on the IMMAGE… | 1986 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- None of the 2 ancestors has a recall.
- 1 other device also cites its predicate K862019.
How does its category compare?
All MSJ devicesMSJ Apolipoproteins: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · MSJ
2in 2008
2026 to Oct 25, outlined.
Median 510(k) review, days · MSJ
Too few MSJ 510(k)s in any year since 2007 to give a median.
Recalls per year · MSJ
No recall names MSJ since 2007.
Adverse event reports per year · MSJ
No MAUDE report names MSJ since 2007.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 2 | — | 0 | 0 |
| 2008 | 2 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 0 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The IMMAGE Immunochemistry System Apolipoprotein A-1 (APA) and B (APB) Reagents, in conjunction with Beckman Apolipoprotein Calibrator (APO Cal), are intended for use in the quantitative determination of apolipoprotein A-1 and B in human serum samples by nephelometric immunoassay. These assays are designed for use with the IMMAGE Immunochemistry System.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K964010 · printed Nov 6, 2026
Cite this page
510(k) Report. “K964010: Immage Immunochemistry System Apolipoprotein a-1 Reagent (Apa)/ Immage Immunochemistry System Apolipoprotein B Reagent.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K964010
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026